October 15, 2020 SITC 2020 – embargo snafu triggers the first movers The SITC breaks its own embargo, and the ensuing chaos sees Replimune, Iovance and Incyte move.
September 30, 2020 Clinical data focus for the smallest players Our final look at upcoming catalysts sees data expected from Replimune, TCR2 Therapeutics, Anavex and more.
October 09, 2019 SITC 2019 preview – Nextcure’s time to shine The biotech calendar’s next key conference gets under way in a month, and a presentation by Nextcure will be a focus for some investors.